Rxcurve
HCPCS J0283 · per 30 MG

Inj, amiodarone (nexterone)

Products billed under this code include Nexterone.

Payment limit per 30 MG, by effective quarter, 2Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J0283

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Nexterone Baxter Healthcare Corporation 43066-0150-10 5 $13.815
Nexterone Baxter Healthcare Corporation 43066-0360-20 12 $33.156

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $2.763 +$0.405 30 MG Inj, amiodarone (nexterone) v1, posted September 17, 2026
3Q26 $2.358 −$0.13 30 MG Inj, amiodarone (nexterone) v1, posted September 15, 2026
2Q26 $2.488 −$0.041 30 MG Inj, amiodarone (nexterone) v1, posted September 15, 2026
1Q26 $2.529 −$0.077 30 MG Inj, amiodarone (nexterone) v1, posted September 15, 2026
4Q25 $2.606 −$0.005 30 MG Inj, amiodarone (nexterone) v1, posted September 8, 2026
3Q25 $2.611 +$0.017 30 MG Inj, amiodarone (nexterone) v1, posted March 10, 2026
2Q25 $2.594 +$0.07 30 MG Inj, amiodarone (nexterone) v1, posted March 10, 2026
1Q25 $2.524 −$0.02 30 MG Inj, amiodarone (nexterone) v1, posted December 19, 2025
4Q24 $2.544 +$0.122 30 MG Inj, amiodarone (nexterone) v1, posted June 11, 2025
3Q24 $2.422 −$0.123 30 MG Inj, amiodarone (nexterone) v1, posted June 11, 2025
2Q24 $2.545 – 30 MG Inj, amiodarone (nexterone) v1, posted March 11, 2025

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files